SLC2A1 and cancer: Given the cancer cells’ high dependence on glucose metabolism and inherent metabolic reprogramming, most cancers show changes in the pattern and level of GLUT expression, with some GLUTs being expressed in tissues where they normally lack and native GLUTs being significantly upregulated5.